What moved PRFN.SW stock today?

Intraday selling and high turnover moved PRFN.SW stock today. Volume was **2,937,350**, about **3.42x** average, and the price fell to **CHF0.0362** as traders reacted to microcap flows rather than fresh company news.

What are the key financial risks for PRFN.SW stock?

Key risks are negative EPS (**-0.001**), limited cash per share (**CHF0.00074**), small enterprise value (**CHF305,000**), and potential dilution from funding needs. These raise downside risk for PRFN.SW stock.

What is Meyka AI’s view and forecast for PRFN.SW stock?

Meyka AI rates PRFN.SW **60.63/100 (B, HOLD)** and projects a 12-month base case of **CHF0.09**, implying **+148.62%** versus **CHF0.0362**. Forecasts are model-based and not guarantees.

How should traders approach PRFN.SW stock intraday?

Traders should use tight stops, size positions for high volatility, watch VWAP and intraday volume spikes, and track support at **CHF0.034** and resistance near **CHF0.07** when trading PRFN.SW stock.

CH Stocks

PRFN.SW Kinarus Therapeutics (SIX) CHF0.0362 -8.12% on 2.94M vol 15 Jan 2026: monitor catalysts

ByHuzaifa Zahoor January 15, 2026January 15, 2026

PRFN.SW stock opened weaker in intraday trade as Kinarus Therapeutics Holding AG (SIX, Switzerland) slid to CHF0.0362, down -8.12% on heavy volume of 2,937,350 shares on 15 Jan 2026. The move broke below the 50-day and 200-day averages near CHF0.07275 and CHF0.07420. Traders cited thin market cap structure and reaction to microcap liquidity flows. We focus on drivers behind the spike in activity and what short-term traders should watch.